A reduced incidence of a severe LARS with rates of 9% in the TNT and 22% in the non-TNT-group ( p = 0.23) showed a favorable trend of functional outcome in the TNT group.
← all excerpts
Total neoadjuvant therapy for locally advanced rectal cancer: barriers to implementation in real-world practice.
1
—
—